Physician Wealth Advisors Inc. Takes $93,000 Position in Intel Co. (NASDAQ:INTC)

Physician Wealth Advisors Inc. acquired a new position in Intel Co. (NASDAQ:INTC) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 4,632 shares of the chip maker’s stock, valued at approximately $93,000.

Other large investors have also recently added to or reduced their stakes in the company. CIBC Private Wealth Group LLC grew its position in shares of Intel by 5.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 490,880 shares of the chip maker’s stock valued at $9,759,000 after purchasing an additional 27,532 shares during the last quarter. RWA Wealth Partners LLC lifted its stake in Intel by 2.6% in the 4th quarter. RWA Wealth Partners LLC now owns 149,540 shares of the chip maker’s stock valued at $2,998,000 after buying an additional 3,760 shares in the last quarter. Summit Securities Group LLC grew its holdings in Intel by 13.6% during the 4th quarter. Summit Securities Group LLC now owns 5,682 shares of the chip maker’s stock valued at $114,000 after buying an additional 682 shares during the last quarter. Allianz SE purchased a new position in Intel during the fourth quarter worth $2,763,000. Finally, Allstate Corp acquired a new position in shares of Intel in the fourth quarter worth $2,541,000. 64.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently commented on INTC. Rosenblatt Securities reiterated a “sell” rating and set a $20.00 price objective on shares of Intel in a research report on Thursday, January 30th. Stifel Nicolaus cut their price objective on shares of Intel from $25.00 to $21.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Mizuho decreased their target price on shares of Intel from $23.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 10th. HSBC upgraded Intel from a “reduce” rating to a “hold” rating in a report on Tuesday, January 21st. Finally, Wells Fargo & Company decreased their price objective on Intel from $28.00 to $25.00 and set an “equal weight” rating on the stock in a report on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, twenty-eight have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $27.04.

Intel Price Performance

Shares of NASDAQ INTC opened at $22.71 on Monday. The company has a market capitalization of $98.33 billion, a price-to-earnings ratio of -5.18 and a beta of 1.02. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.33 and a quick ratio of 0.98. Intel Co. has a 1-year low of $18.51 and a 1-year high of $45.41. The business has a 50-day moving average of $22.33 and a 200-day moving average of $22.16.

Intel (NASDAQ:INTC) last released its quarterly earnings results on Thursday, January 30th. The chip maker reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.14). Intel had a negative return on equity of 3.27% and a negative net margin of 35.32%. On average, equities analysts anticipate that Intel Co. will post -0.11 EPS for the current fiscal year.

Intel Profile

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.